Name: CJC-1295 No DAC 10mg + Ipamorelin 10mg (10 Vials / Kit)
Brand: European Peptide Sciences
SKU: EP-CJCIPA
Price: 620.00 USD
Availability: InStock

CJC-1295 (No DAC) + Ipamorelin at a glance

Two peptides are co-lyophilized here. CJC-1295 without DAC, more precisely called Modified GRF 1-29, is a version of the active 1-29 portion of GHRH with substitutions at several positions that make it harder for enzymes to break down. Ipamorelin is a synthetic pentapeptide that acts on the ghrelin receptor. Neither molecule carries the Drug Affinity Complex, the albumin-binding group found in CJC-1295 with DAC, so both remain short-acting in pharmacology studies.

Price and availability

A 10mg + 10mg listing from European Peptide Sciences, shipped from the Netherlands. It is listed at $620.00. Checkout goes into escrow first; the funds move to European Peptide Sciences once delivery is confirmed.

This listing: European Peptide Sciences CJC-1295 No DAC

Brand: European Peptide Sciences
Kit: 10 vials
Price per vial: $62.00
Also sold by: Kensington Biosciences CJC-1295 No DAC 10mg + Ipamorelin 10mg $480.00

Lab testing

There is no public lab report for this listing yet. We can ask the brand for the batch COA before you order. Many buyers also split an independent HPLC test with others who bought the same batch.

Request the batch COA · How group testing works

Bought through escrow: the brand is only paid after you confirm delivery. If the parcel never arrives, or an independent test shows the wrong compound or a significant under-fill, open a claim before releasing payment.

What it is studied for

The two components act through different receptors on the same pituitary cells. Modified GRF 1-29 binds the GHRH receptor, while Ipamorelin binds GHS-R1a, the receptor for the stomach hormone ghrelin. GHRH signaling raises cyclic AMP, whereas ghrelin-receptor signaling works mainly through calcium and also opposes the inhibitory effect of somatostatin. Researchers pair them to see how two distinct inputs shape a growth hormone pulse. Ipamorelin is noted in the literature for releasing growth hormone with little measured effect on cortisol or prolactin in animal studies.

Research and regulatory status

Each peptide has a preclinical record, and Ipamorelin was also tested in early human trials for postoperative ileus without reaching approval. The pairing is common in research on GH secretion patterns, body composition and recovery, typically using pituitary cell assays or animal models. Neither component, nor the blend, is an approved medicine, and both fall within the World Anti-Doping Agency prohibited list.

Checking the lab data

A blend report should identify both peptides individually. Mass spectrometry should confirm Modified GRF 1-29 and Ipamorelin at their expected masses, and an HPLC trace should separate the two peaks and quantify each against the labeled amounts. A version containing DAC would show a much heavier mass, so the result also confirms the No DAC form. Expect a white, uniform freeze-dried cake and a batch number matching the vial.

No independent report is attached to this listing yet. You can compare brands that publish one on the CJC-1295 (No DAC) + Ipamorelin page or browse the lab reports directory.

Listing details

Compound: CJC-1295 (No DAC) + Ipamorelin
Synonyms: Mod GRF 1-29 + Ipamorelin blend
Class: GHRH analogue / ghrelin-receptor agonist combination
Format: Lyophilized (freeze-dried) powder
Vial strength: 10mg + 10mg
Vials per kit: 10
Sold by: European Peptide Sciences
Ships from: Netherlands
Lab report: Not yet published

Storage and preparation

Store sealed and as the label directs, away from heat and direct light. Discard anything with a broken seal or cloudy contents.

Buyer questions

Is CJC-1295 No DAC the same as Mod GRF 1-29?

In practice, yes. The research peptide sold as CJC-1295 without DAC is the modified GHRH 1-29 sequence commonly called Mod GRF 1-29. The CJC-1295 name originally referred to the version with the albumin-binding DAC group, so the naming is a market convention rather than a formal designation.

What makes Ipamorelin selective?

Earlier ghrelin-receptor agonists such as GHRP-2 and GHRP-6 were reported to raise cortisol, prolactin or appetite alongside growth hormone. In animal studies Ipamorelin produced GH release with comparatively little change in those other hormones, which is why it is described as selective. That profile comes mainly from preclinical work and small early studies.

When does European Peptide Sciences get paid?

Only after you confirm delivery. Until then the payment is held in escrow, and you can open a claim if anything is wrong with the order.

Supplied for laboratory research only. Not for human or veterinary use, and not a substitute for any prescription medicine. Nothing on this page is medical advice.